Added to YB: 2026-05-11
Pitch date: 2026-04-30
GBT.PA [neutral]
Guerbet SA
-8.17%
current return
Author Info
No bio for this author
Company Info
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide.
Market Cap
EUR 139.5M
Pitch Price
EUR 11.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.97
P/E
-1.29
EV/Sales
0.57
Sector
Health Care Equipment and Supplies
Category
turnaround
The European Deep Value Week – 2026/17 | Guerbet – Q1 revenue rises at constant exchange rates
GBT.PA (update): Q1 rev €177.4M, -1.5% reported but +2.6% CER. EMEA +4.5%, Asia +6%, Americas -3% on Raleigh batch delays (normalizing by YE). Diagnostic Imaging +1.9% on MRI/Elucirem rollout; Interventional Radiology +7.8% on Lipiodol. Transformation ongoing, financing talks w/ lenders. 2026 targets by Jul 23.
Read full article (1 min)